1. Home
  2. PSQH vs INKT Comparison

PSQH vs INKT Comparison

Compare PSQH & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

HOLD

Current Price

$1.09

Market Cap

62.4M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.82

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSQH
INKT
Founded
2021
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.4M
51.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PSQH
INKT
Price
$1.09
$11.82
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$6.00
$35.00
AVG Volume (30 Days)
596.7K
20.6K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,534,522.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
196.08
N/A
52 Week Low
$0.92
$4.56
52 Week High
$5.18
$76.00

Technical Indicators

Market Signals
Indicator
PSQH
INKT
Relative Strength Index (RSI) 33.88 50.06
Support Level $1.07 $11.33
Resistance Level $1.22 $12.31
Average True Range (ATR) 0.10 0.73
MACD -0.00 0.07
Stochastic Oscillator 31.58 46.54

Price Performance

Historical Comparison
PSQH
INKT

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: